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Background: While knowledge and risk perception have been associated with screening for second primary cancer
(SPC), there are no clinically useful indicators to identify who is at risk of not being properly screened for SPC. We
investigated whether the mode of primary cancer detection (i.e. screen-detected vs. non-screen-detected) is
associated with subsequent completion of all appropriate SPC screening in cancer survivors.
Methods: Data were collected from cancer patients treated at the National Cancer Center and nine regional cancer
centers across Korea. A total of 512 cancer survivors older than 40, time since diagnosis more than 2 years, and
whose first primary cancer was not advanced or metastasized were selected. Multivariate logistic regression was
used to examine factors, including mode of primary cancer detection, associated with completion of all appropriate
SPC screening according to national cancer screening guidelines.
Results: Being screen-detected for their first primary cancer was found to be significantly associated with
completion of all appropriate SPC screening (adjusted odds ratio, 2.13; 95% confidence interval, 1.36–3.33), after
controlling for demographic and clinical variables. Screen-detected cancer survivors were significantly more likely to
have higher household income, have other comorbidities, and be within 5 years since diagnosis.
Conclusions: The mode of primary cancer detection, a readily available clinical information, can be used as an
indicator for screening practice for SPC in cancer survivors. Education about the importance of SPC screening will
be helpful particularly for cancer survivors whose primary cancer was not screen-detected.
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With unprecedented innovation in detection, diagnosis,
and treatment for cancer over the recent years, the over-
all survival rate for cancer has significantly increased [1].
As a result, the number of cancer survivors more than
tripled from 1970 to 2000, totaling around 11.1 million
in the US [2], and cancer survivorship is becoming more
and more an important clinical topic [3]. Among various
aspects of this survivorship, screening for second* Correspondence: dwshin@snuh.org; whitemiso@ncc.re.kr
†Equal contributors
1Department of Family Medicine & Health Promotion Center, Seoul National
University Hospital, Seoul, Republic of Korea
3Division of Cancer Policy and Management, National Cancer Control
Institute, National Cancer Center, Goyang, Republic of Korea
Full list of author information is available at the end of the article
© 2012 Suh et al.; licensee BioMed Central Ltd
Commons Attribution License (http://creativec
reproduction in any medium, provided the orprimary cancer (SPC) is an important topic. Cancer
survivors are at higher risk to develop cancer [4,5], and
SPC is associated with increased mortality [6]. There-
fore, early detection by screening for SPC may be an ef-
fective way to lower the mortality of cancer survivors as
a whole.
Previous studies show that cancer survivors are more
likely to undergo cancer screening compared to people
without cancer [7-9], nonetheless, the rate was shown to
be suboptimal [10]. Some factors [10-12] have been
shown to be associated with screening behaviors in can-
cer survivors, including knowledge and risk perception
regarding SPC. However, these factors are rather an
array of conceptual and subjective information of a pa-
tient that are not always clearly assessable by doctors in. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Sample selection algorithm for analysis used in this
study.
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signs or indicators, if any, will be useful to identify who
is at risk of not completing appropriate screening for
SPC.
In this study, we investigated whether the mode of pri-
mary cancer detection (i.e. screen-detected vs. non-
screen-detected) is associated with subsequent comple-
tion of all appropriate second primary cancer (SPC)
screening in cancer survivors. We also investigated fac-
tors associated to the mode of primary cancer detection
in order to evaluate other possible indicators that may
be involved in the screening behavior of cancer
survivors.
Methods
Participants and procedures
This study was performed as a part of an annual national
survey to investigate the experience of cancer survivors.
This study was approved by the Institutional Review
Board of the National Cancer Center in Korea.
Using the quota sampling method, patients were
recruited from 10 cancer centers (one national cancer
center and the regional cancer centers in each of the
nine Korean provinces) in Korea so that the perspective
of patients with cancer common to Koreans, as well as
that of patients of different gender and ages was repre-
sented as fairly as possible. Patients were included in this
study if they were older than 18 years of age, used the
inpatient or outpatient facilities of at least one of
these 10 cancer centers, and agreed to participate. About
200 patients were recruited from each of the 10 cancer
centers. To reflect national prevalence of each cancer
types, 80% of the recruited patients were to be of the six
major types of cancer (stomach, lung, liver, colon and
rectal, breast, and cervical) and 20% of others.
Pilot surveys in each cancer center were first con-
ducted using the survey methods employed in this study.
No problems were found in the pilot study with patient
understanding of the questions or with face or content
validity of the questionnaires. Over a period of two
months, cancer patients who gave written informed con-
sent to participate in the study were interviewed by
trained evaluators. A total of 1,956 cancer patients from
the 10 cancer centers completed the interview process.
In addition to the survey, medical chart audits were
performed to obtain histological and Surveillance
Epidemiology and End Results (SEER) stage information
(version 2000) [13].
For our study purposes in this particular study, from
the original total of 1,956 cancer patients, we excluded
patients younger than age 40 (N = 138), in order to spe-
cifically analyze the subpopulation of patients recom-
mended to be screened regularly by the current
guidelines in Korea (details of the guidelines describedin the “Measures and outcomes” section below). Patients
with advanced disease, namely those diagnosed with re-
curred or distant disease in respect to SEER staging,
were excluded (N = 429), because the benefit of screen-
ing in those patients is limited due to their low 5-year
survival rates. Patients with time since diagnosis less
than 2 years were also excluded (N = 877) because in our
outcome variable, completion of appropriate screening,
screening is recommended at least every 2 years, and
screening tests should be performed after cancer diagno-
sis. Of the original 1,956 subjects, 1,444 subjects were
excluded and the final number of subjects for analysis
was 512 (Figure 1).
Measures and outcomes
The mode of detection of the cancer survivors’ first pri-
mary cancer, which is our main explanatory variable of
interest, was determined by a survey question of “How
was your cancer discovered?”, for which the answer
choices were: (1) “I had a certain symptom of discomfort
that prompted me to visit the hospital”; (2) “My cancer
was discovered incidentally through routine screening”;
(3) “My cancer was discovered incidentally while being
tested for another condition”; and (4) “Others.” We
defined “screen-detected” cancer patients as those who
answered this question as (2) “My cancer was discovered
incidentally through routine screening,” and defined
“non-screen-detected” cancer patients as those who
answered otherwise.
Questions regarding screening practices were adopted
from the Korean National Health and Nutrition Survey
(KNHANES) [14], and addressed whether individuals
had ever undergone examinations for breast cancer
(mammogram or breast sonography), stomach cancer
(endoscopy or upper gastrointestinal series), cervical
cancer (Papanicolaou test), or colorectal cancer (fecal
occult blood test, sigmoidoscopy, colonoscopy, or bar-
ium enema). A positive answer to any screening ques-
tion was followed by questions about the timing of the
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>5 years, or none). We used “completion of all appropri-
ate screening” as the main study outcome variable. Be-
cause to our knowledge there is no consensus regarding
the optimal cancer screening strategy in Korean cancer
survivors, an operational definition of appropriate
screening in the current study was developed based on
the National Cancer Screening Program in Korea [15]:
(1) endoscopy or upper gastrointestinal series in the pre-
vious 2 years for stomach cancer screening (age ≥ 40);
(2) sigmoidoscopy, colonoscopy, or barium enema in
the previous 5 years for colorectal cancer screening
(age ≥ 50); (3) mammogram or breast sonography in the
previous 2 years for breast cancer screening (age ≥ 40);
(4) Papanicolaou test in the previous 2 years for cervical
cancer screening (age ≥ 30). Moreover, cancer survivors
with specific first primary cancer that the screening
aimed to detect were excluded from each calculation [9]
(e.g. gastric cancer screening for gastric cancer patients
were discarded), because such follow-up exams are
carried out to monitor recurrence, rather than screen
for SPC.
The survey also included socio-demographic factors
known to be associated with screening practices, includ-
ing age [16,17], gender [18], marital status [16,19], edu-
cation [16,17,20], monthly household income [19,21,22],
smoking status [17], and alcohol consumption [22].
Medical factors included type of cancer, SEER stage,
comorbidity, and time since diagnosis. Information
regarding the presence of comorbidities was also collected
because such conditions are associated with cancer
screening practices [20,23] and included hypertension,
dyslipidemia, diabetes, osteoarthritis, rheumatoid arthri-
tis, and cerebrovascular, cardiovascular, chronic liver, lung,
kidney, or gastrointestinal diseases. Clinical variables, in-
cluding the date of the primary cancer diagnosis, and stage
of disease at the time of diagnosis were collected through
review of medical records.
Statistical analyses
Descriptive statistics were used to report screening prac-
tices of cancer survivors. We developed two multivariate
logistic regression models: one to examine the factors
associated with the completion of all appropriate screen-
ing, and the other to examine the factors associated with
the mode of detection. Missing data were <1% for all
variables. All analyses were conducted using STATA ver-
sion 11.0. Statistical significance was specified when p-
values were <0.05.
Results
Study population
The mean age of the study subjects was 59.6 ± 10.2 years;
265 (51.8%) were 60 years of age or older, and 250(48.8%) were male. Stomach cancer was the most com-
mon diagnosis, followed by breast and colorectal cancer.
Mean time since cancer diagnosis was 5.1 ± 3.3 years
(Table 1).
SPC screening practices
The overall SPC screening rate with the age and time
corresponding to the guidelines of each cancer for stom-
ach, colorectal, breast, and cervical cancer were 37.9%,
39.2%, 29.0%, 53.4%, respectively (Table 2). Completion
rate of all appropriate SPC screening was 36.9% (Table 2)
for overall, 32.0% for non-screen detected, and 50.4% for
screen-detected survivors, respectively (Table 3).
Factors associated with completion of all SPC screening
In univariate analysis, younger age (odds ratio [OR],
1.65; 95% confidence interval [95% CI], 1.15–2.37), male
gender (OR, 1.76; 95% CI, 1.22–2.53), higher education
(OR, 1.89; 95% CI, 1.26–2.83), alcohol consumption
(OR, 1.87; 95% CI, 1.13–3.12), and being screen-detected
for primary cancer (OR, 2.16; 95% CI, 1.45–3.21) were
associated with completion of all appropriate screening.
In munltivariate-adjusted analysis, younger age (adjusted
odds ratio [aOR], 2.09; 95% 95% CI, 1.32–3.31), and
being screen-detected (aOR, 2.13; CI, 1.36–3.33) were
found to be significantly associated with completion of
all appropriate screening. There was also marginal signifi-
cance with higher education (aOR, 1.57; CI, 0.96–2.57)
(Table 3).
Characteristics of patients by mode of first primary
cancer detection
Screen-detected cancer survivors were significantly more
likely to have higher household income (aOR, 2.23; CI,
1.39–3.58), have other comorbidities (aOR, 2.05; CI,
1.29–3.28). Survivors with 5 years or more since diagno-
sis were less likely to be screen-detected (aOR, 0.60; CI,
0.38–0.94). Prevalence of screen-detected patients were
highest among stomach cancer patients, followed by
liver, lung, breast, cervical, other, and colorectal cancer
patients (36.8%, 33.3%, 30.8%, 29.2%, 21.4%, 19.4%,
16.2%) (Table 4).
Discussion
To our knowledge, the current study, carried out with a
relatively large nationally representative sample, is the
first to examine the association between the mode of
primary cancer detection and subsequent SPC screening
in cancer survivors. We have shown that the mode of
primary cancer detection may be used as a useful clinical
indicator for SPC screening practices in cancer survi-
vors. No specific comparison to other related studies for
our key finding was possible because our study is the
only study that investigated the association between the
Table 1 Characteristics of study participants
Socio-demographic characteristics N (%) Medical characteristics N (%)
Age [Mean ± SD] [59.6 ± 10.2 y] Cancer types
40≤ y < 60 247 (48.2) Stomach 106 (20.7)
≥ 60 y 265 (51.8) Lung 39 (7.6)
Gender Liver 42 (8.2)
Female 262 (51.2) Colon/Rectum 74 (14.5)
Male 250 (48.8) Breast 113 (22.1)
Marital status Cervix 14 (2.7)
Not married (single, divorced, widowed) 87 (17.0) Others 124 (24.2)
Married 425 (83.0) Stage
Education In situ & local 282 (55.1)
Less than high school 165 (32.2) Regional 230 (44.9)
High school and above 347 (67.8) Comorbidity
Monthly household income No 189 (36.9)
<2 million won 361 (70.5) Yes 323 (63.1)
≥2 million won 151 (29.5) Years since diagnosis [Mean±SD] [5.1 ± 3.3 y]
Insurance 2≤ y <5 327 (63.8)
Medicaid/none/others 94 (18.4) ≥5 y 185 (36.1)
National health insurance 418 (81.6)
Abbreviations: SD standard deviation, N number, y year.
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screening in cancer survivors, which is a unique setting
different from primary cancer screening.
In our study, only 36.9% of cancer survivors completed
all age, sex- appropriate screening for SPC. This figure isTable 2 Screening practice for second primary cancer among
Stomach
Cancer
Survivors*
Lung Cancer
Survivors
Liver Cancer
Survivors
Colore
Cance
Surviv
N (%) N (%) N (%) N (%)
Men Women Men Women Men Women Men
N =
81
N = 25 N =
25
N = 14 N =
30
N = 12 N =
51
Stomach cancer
screening
NA NA 16
(64.0)
12
(85.7)
12
(40.0)
5 (41.7) 19
(37.3)
Colorectal
cancer
screening**
32
(47.1)
8 (47.1) 13
(54.2)
9 (69.2) 16
(47.5)
3 (25.0) NA
Breast cancer
screening***
NA 12
(48.0)
NA 8 (57.1) NA 6 (50.0) NA
Cervical cancer
screening***
NA 14
(56.0)
NA 9 (64.3) NA 5 (41.7) NA
Complete
cancer
screening
45
(55.6)
9 (36.0) 14
(56.0)
6 (42.9) 10
(33.3)
3 (25.0) 19
(37.3)
Abbreviations: NA not applicable, N number.
*Only patients not having the specific type of cancer were included for the cancer
screening, etc.
**The overall rate of colorectal cancer screening has been calculated only among su
50 were automatically classified as having completed colorectal cancer screening, b
current guidelines. Hence, male stomach cancer survivors younger than 50 were au
without having received any screening exam.
***The overall rates of breast cancer screening and cervical cancer screening have bsimilar to previous studies performed in Korea [12], and
confirms the need to increase screening rates in this popu-
lation. Therefore, identification of high risk group for
non-completion of SPC screening would be meaningful
from both clinical and public health care perspectives.cancer survivors
ctal
r
ors*
Breast Cancer
Survivors*
Cervical
Cancer
Survivors*
Other Cancer
Survivors
All
Survivors
N (%) N (%) N (%) N (%)
Women N = 113 N = 14 Men Women N = 512
N = 23 N =
63
N = 61
8 (34.8) 55 (48.7) 5 (35.7) 30
(47.6)
32
(52.5)
194 (37.9)
NA 32 (43.8) 5 (38.5) 23
(39.7)
23
(51.1)
164 (39.2)
8 (34.8) NA 6 (42.9) NA 36
(59.0)
76 (29.0)
9 (39.1) 69 (61.1) NA NA 34
(55.7)
140 (53.4)
6 (26.1) 27 (23.9) 4 (28.6) 21
(33.3)
25
(41.0)
189 (36.9)
screening, e.g. stomach cancer survivors were not subject to stomach cancer
bjects of age 50 or more (N = 418). Cancer survivors who were younger than
ecause they were not recommended to be screened for colorectal cancer by
tomatically classified as having completed all appropriate SPC screening
een calculated only among female subjects (N = 262).
Table 3 Factors associated with completion of all appropriate SPC screening
Completion of All Appropriate SPC Screening
No Yes Univariate Multivariate*
N (%) N (%) OR (95% CI) OR (95% CI)
Age
Old (≥60 y) 182 (68.7) 83 (31.3) 1.00 1.00
Young (40 ≤ y <60) 141 (57.1) 106 (42.9) 1.65 (1.15–2.37) 2.09 (1.32–3.31)
Gender
Female 182 (69.5) 80 (30.5) 1.00 1.00
Male 141 (56.4) 109 (43.6) 1.76 (1.22–2.53) 1.45 (0.87–2.41)
Marital status
Not married (single, divorced, widowed) 56 (64.4) 31 (35.6) 1.00 1.00
Married 267 (62.8) 158 (37.2) 1.07 (0.66–1.73) 0.69 (0.40–1.21)
Education
Less than high school 120 (72.7) 45 (27.3) 1.00 1.00
High school and above 203 (58.5) 144 (41.5) 1.89 (1.26–2.83) 1.57 (0.96–2.57)
Monthly household income
<2 million won 233 (65.5) 128 (35.5) 1.00 1.00
≥2 million won 90 (59.6) 61 (40.4) 1.23 (0.84–1.82) 0.91 (0.57–1.44)
Insurance
Medicaid/none/others 65 (69.2) 29 (30.9) 1.00 1.00
National health insurance 258 (61.7) 160 (38.3) 1.39 (0.86–2.25) 1.46 (0.84–2.52)
Cancer types
Stomach 52 (49.1) 54 (50.9) 1.00 1.00
Lung 19 (48.7) 20 (51.3) 1.01 (0.49–2.11) 1.46 (0.65–3.27)
Liver 29 (69.1) 13 (31.0) 0.43 (0.20–0.92) 0.47 (0.21–1.05)
Colon/Rectum 49 (66.2) 25 (33.8) 0.49 (0.27–0.91) 0.57 (0.29–1.12)
Breast 86 (76.1) 27 (23.9) 0.30 (0.17–0.54) 0.31 (0.15–0.64)
Cervix 10 (71.4) 4 (28.6) 0.39 (0.11–1.31) 0.65 (0.17–2.48)
Others 78 (62.9) 46 (37.1) 0.67 (0.34–0.96) 0.72 (0.40–1.28)
Stage
In situ & local 182 (64.5) 100 (35.5) 1.00 1.00
Regional 141 (61.3) 89 (38.7) 1.15 (0.80–1.65) 1.19 (0.79–1.79)
Years since diagnosis
2≤ y <5 200 (61.2) 127 (38.8) 1.00 1.00
≥5 y 123 (66.5) 62 (33.5) 0.79 (0.54–1.16) 0.95 (0.63–1.43)
Comorbidity
No 124 (65.6) 65 (34.4) 1.00 1.00
Yes 199 (61.6) 124 (38.4) 1.19 (0.82–1.73) 0.94 (0.62–1.42)
Smoking, current
No 305 (63.4) 176 (36.6) 1.00 1.00
Yes 18 (58.1) 13 (41.9) 1.25 (0.60–2.62) 1.04 (0.46–2.36)
Drinking, current
No 288 (65.2) 154 (34.8) 1.00 1.00
Yes 35 (50.0) 35 (50.0) 1.87 (1.13–3.12) 1.53 (0.86–2.70)
Mode of first primary cancer detection
Non-screen-detected 255 (68.0) 120 (32.0) 1.00 1.00
Screen-detected 68 (49.6) 69 (50.4) 2.16 (1.45–3.21) 2.13 (1.36–3.33)
Abbreviations: N number, y year, OR odds ratio, CI confidence interval.
*Adjusted for all variables in univariate analysis.
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Table 4 Characteristics of subjects by mode of first primary cancer detection
Mode of First Primary Cancer Detection
Non-screen-detected Screen-detected Univariate Multivariate*
N (%) N (%) OR (95% CI) aOR (95% CI)
Age
Old (≥60 y) 201 (75.9) 64 (24.2) 1.00 1.00
Young (40 ≤ y <60) 174 (70.5) 73 (29.6) 1.32 (0.89–1.95) 0.91 (0.55–1.51)
Gender
Female 192 (73.3) 70 (26.7) 1.00 1.00
Male 183 (73.2) 67 (26.8) 1.00 (0.68–1.49) 0.99 (0.56–1.74)
Marital status
Not married (single, divorced, widowed) 67 (77.0) 20 (23.0) 1.00 1.00
Married 308 (72.5) 117 (27.5) 1.27 (0.74–2.19) 0.97 (0.53–1.79)
Education
Less than high school 131 (79.4) 34 (20.6) 1.00 1.00
High school and above 244 (70.3) 103 (29.7) 1.68 (1.07–2.62) 1.41 (0.83–2.41)
Monthly household income
<2 million won 284 (78.7) 77 (21.3) 1.00 1.00
≥2 million won 91 (60.3) 60 (39.7) 2.43 (1.61–3.67) 2.23 (1.39–3.58)
Insurance
Medicaid/none/others 74 (78.7) 20 (21.28) 1.00 1.00
National health insurance 301 (72.0) 117 (28.0) 1.40 (0.82–2.40) 1.17 (0.64–2.15)
Cancer types
Stomach 67 (63.2) 39 (36.8) 1.00 1.00
Lung 27 (69.2) 12 (30.8) 0.76 (0.35–1.68) 0.80 (0.34–1.88)
Liver 28 (66.7) 14 (33.3) 0.86 (0.40–1.82) 0.85 (0.38–1.90)
Colon/Rectum 62 (83.8) 12 (16.2) 0.33 (0.16–0.69) 0.33 (0.15–0.72)
Breast 80 (70.8) 33 (29.2) 0.71 (0.40–1.25) 0.56 (0.27–1.17)
Cervix 11 (78.6) 3 (21.4) 0.47 (0.12–1.78) 0.41 (0.09–1.77)
Others 100 (80.7) 24 (19.4) 0.41 (0.23–0.75) 0.38 (0.20–0.72)
Stage
In situ & local 203 (72.0) 79 (28.0) 1.00 1.00
Regional 172 (74.8) 58 (25.2) 0.87 (0.58–1.29) 0.92 (0.59–1.42)
Years since diagnosis
2≤ y <5 231 (70.6) 96 (29.4) 1.00 1.00
≥5 y 144 (77.8) 41 (22.2) 0.69 (0.45–1.04) 0.60 (0.38–0.94)
Comorbidity
No 154 (81.5) 35 (18.5) 1.00 1.00
Yes 221 (68.4) 102 (31.6) 2.03 (1.31–3.14) 2.05 (1.29–3.28)
Smoking, current
No 350 (72.8) 131 (27.2) 1.00 1.00
Yes 25 (80.7) 6 (19.4) 0.64 (0.26–1.60) 0.68 (0.26–1.80)
Drinking, current
No 322 (72.9) 120 (27.2) 1.00 1.00
Yes 53 (75.7) 17 (24.3) 0.86 (0.48–1.55) 0.62 (0.32–1.20)
Abbreviations: N number, y year, OR odds ratio, CI confidence interval.
*Adjusted for all variables in univariate analysis.
Suh et al. BMC Cancer 2012, 12:557 Page 6 of 9
http://www.biomedcentral.com/1471-2407/12/557
Suh et al. BMC Cancer 2012, 12:557 Page 7 of 9
http://www.biomedcentral.com/1471-2407/12/557Our results show that screen-detected cancer survivors
are approximately twice more likely to receive all appro-
priate SPC screening, even after controlling for other
covariates which may affect cancer screening behaviors.
Therefore, the mode of primary cancer detection sepa-
rates two subpopulations of cancer survivors with differ-
ing risk for not receiving proper SPC screening, serving
as a clinical indicator.
According to the Health Belief Model (HBM), people
will take action to prevent, screen for, or control their
health conditions if they believe they are susceptible, be-
lieve the condition would have serious consequences,
and believe there is benefit to taking a course of action
[24]. The role of better knowledge [25,26], a positive at-
titude [27], and perceived risk [28] in cancer screening
practices are well known in the general population.
Similar findings have been reported in cancer survi-
vors regarding SPC screening about the role of know-
ledge [12] and risk perception of SPC [11,12]. It was
reported that cancer survivors often could not differenti-
ate SPC from “recurrence” or “metastasis,” and could
not make a distinction between “cancer screening” and
“routine surveillance test” after cancer treatment [29].
Such lack of knowledge [12] was significantly associated
with failed completion of all appropriate SPC screening
in cancer survivors. In addition, a considerable portion
of cancer survivors perceived their cancer risk as lower
than that of the general population, and such mispercep-
tion of SPC risk were negatively associated with screen-
ing for SPC. While those studies provide theoretical
insight on the screening behavior of cancer survivors, it
is impractical to collect information regarding their
knowledge and risk perception in the clinical setting,
their clinical utility being limited.
We suspect that the mode of primary cancer detection
could be an indicator of such knowledge or risk percep-
tion of SPC in cancer survivors for the following rea-
sons. First, people who generally have good knowledge
on the benefit of cancer screening and proper risk per-
ception are more likely to receive cancer screening, and
in case they are diagnosed with cancer, they are most
likely to become screen-detected cancer survivors. Sec-
ond, the personal experience of discovering their cancer
through screening would provide the knowledge that
screening is critical to early detection and effective treat-
ment of cancer. Unfortunately, our survey did not in-
clude specific questions about the cancer survivors’
knowledge and risk perception, therefore, our explan-
ation for the association can only remain hypothetical.
It is interesting to note one of our observations that
having been diagnosed with primary cancer for more
than 5 years is associated with being non-screen-
detected (Table 4). This can be attributed to the recently
developed and propagated national cancer screeningprogram in Korea which, launched in 1999, has success-
fully increased its participation rate from 12.7% in 2002
to 27.8% in 2008, and is projected to have increased fur-
ther [30]. As our survey has been carried out in 2008,
our observations reflect such drastic changes in national
screening rates.
The rate of liver or lung cancer survivors to be screen-
detected has been shown to be overall higher than that
of stomach, colorectal, breast, or cervical cancer survi-
vors, which are cancer types with specific screening
recommendations (Table 4). This may be interpreted as
counterintuitive and we have two main explanations for
these observations. One, considering our study excluded
subjects with less than 2 years since diagnosis, recur-
rence, or distant disease, and also considering the rela-
tively high 5-year mortality rate of lung or liver cancer
in Korea [31], we suspect there is a selection bias toward
screen-detected lung or liver cancer survivors. Two,
early detection of lung or liver cancer involves low dose
chest computed tomography or abdomen ultrasonog-
raphy, respectively, which are procedures in Korea only
offered (to asymptomatic subjects without particular
indications) in commercial private health screening pro-
grams, but not in government screening programs that
strictly abide to specific screening recommendations
[32]. Therefore, mostly health-conscious subjects are ex-
clusively willing to pay the high price for such health
packages, a phenomenon not unique in Korea [33]. This
would be a source of selection bias not exclusive to our
study, but to lung or liver cancer survivors (with more
years since diagnosis) in general, that well explains such
aforementioned counterintuitive observations. We re-
gard these observations to be very interesting, because a
further study on the particular nature of mode of pri-
mary cancer detection (whether it be screening via gov-
ernment programs or commercial programs) and its
association to completion of all appropriate SPC screen-
ing will most likely add predictive value to identifying
high risk cancer survivors at risk of not properly receiv-
ing proper SPC screening.
It is to be emphasized that our results and implica-
tions are especially significant in that we considered
completion of all appropriate SPC screening rather than
single type SPC screening. Most previous studies investi-
gating the barriers associated to screening have evalu-
ated screening of single, specific cancer types [17,22],
and according to a large US study, only 3% of women
and 5% of men older than 50 had completed all appro-
priate cancer screening for their age and sex [34]. This
fact should be noted in context to 1) various public cam-
paigns for single type cancer screening, as in the case of
pink ribbon breast cancer campaign [35], and 2) many
practices that provide only one or two screening tests. In
fact, in our results, compared to stomach cancer
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associated to non-completion of all appropriate SPC
screening (aOR 0.31, 95% CI 0.15–0.64; Table 3). We
therefore assert that analysis of factors associated with
completion of all appropriate SPC screening would more
accurately reflect cancer survivors’ knowledge and per-
ception of SPC screening, and hence be better predictive
of their SPC screening behavior, than that of single type
SPC screening.
There are several limitations to our current study.
First, there is a source of imprecision in terms of the
definition of SPC screening in our sample and its corres-
pondence to time since diagnosis, especially for colorec-
tal cancer screening. Due to limitation of sample size,
our analysis includes cancer survivors with time since
diagnosis from 2 years and more. Because colorectal
cancer screening guidelines recommend screening every
5 years after age 50, those with time since diagnosis less
than 5 years (and older than 50) may not have been sub-
ject to SPC screening for colorectal cancer and conse-
quently we may have accounted for primary cancer
screening. However, sensitivity analysis (data not shown)
among patients with time since diagnosis beyond 5 years
show similar magnitude of association and statistical sig-
nificance of factors associated with completion of all ap-
propriate SPC screening. Second, the assessment of
cancer screening practices was based on participants’
self-report, subject to recall bias. Although we used care-
fully phrased questions which were used in KNHANES
[14] to maximize accuracy, it is possible that survivors
with less knowledge may have also had more difficulty
understanding the questions correctly or may have
undergone screening tests without realizing that they
were performed for screening purposes. Third, despite of
our study’s multicenter, nationwide design, our study
sample was not large enough to allow subgroup analysis
by primary cancer type. It is possible that the behaviors
may differ among survivors with different primary can-
cers. Fourth, we cannot statistically assess the represen-
tativeness of our sample. Instead, we employed quota
sampling to obtain a similar distribution of cancer types
to the general Korean cancer population. In addition,
our gender and age group distributions were not biased.
Overall, we assert that this limitation does not lead to
serious problems with internal validity or representation,
and there has been previous studies based on the same
survey [36].
Despite above-mentioned limitations, our study sug-
gests that the mode of primary cancer detection, a read-
ily available clinical information, can be used as an
indicator for screening practice for SPC in cancer survi-
vors. Education about the importance of SPC screening
will be helpful particularly for cancer survivors whose
primary cancer was not screen-detected.Conclusions
We have identified non-screen-detected cancer survivors
as a subpopulation at risk of improper SPC screening
behavior. We suggest that all cancer survivors must be
inquired about how their primary cancer were detected,
and extensive emphasis and education on the import-
ance of SPC screening must be provided, especially, for
non-screen-detected cancer survivors by their physicians
in the clinic.
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